Back to Search Start Over

The usual medical care for irritable bowel syndrome

Authors :
William E. Whitehead
Douglas A. Drossman
M Von Korff
Olafur S. Palsson
Rona L. Levy
Andrew D. Feld
Marsha J. Turner
Source :
Alimentary Pharmacology & Therapeutics. 20:1305-1315
Publication Year :
2004
Publisher :
Wiley, 2004.

Abstract

Summary Aims : To determine what constitutes usual medical care for irritable bowel syndrome, which patient characteristics influence choice of treatment and how satisfied patients are with care. Methods : Patient encounters in a health maintenance organization were prospectively monitored to identify visits coded irritable bowel syndrome, abdominal pain, constipation or diarrhoea. Within 2 weeks these patients were sent postal questionnaires (n = 1770, 59% participation) to assess patient characteristics and treatment recommendations. Responders were sent follow-up questionnaires 6 months later (77% participation) to assess adherence and satisfaction with treatment. Results : Treatments employed most frequently were dietary advice, explanation, exercise advice, reassurance, advice to reduce stress and antispasmodic medications. Primary care physicians and gastroenterologists provided similar treatments. Patient confidence was higher for lifestyle advice (63–67, 100-point scale) than for medications (46–59). However, adherence was greater for medications (62–79 vs. 59–69, 100-point scale). Satisfactory relief was reported by 57%, but only 22% reported that symptom severity was reduced by half. Usual medical treatment was less effective for irritable bowel syndrome than for constipation, diarrhoea, or abdominal pain. Conclusions : Usual medical care for irritable bowel syndrome emphasizes education and lifestyle modification more than drugs; patients have a greater expectation of benefit from lifestyle modification than drugs. Overall 57% of irritable bowel syndrome patients report satisfactory relief.

Details

ISSN :
02692813
Volume :
20
Database :
OpenAIRE
Journal :
Alimentary Pharmacology & Therapeutics
Accession number :
edsair.doi...........c8b01119459bca05ea472031ad0eab6d
Full Text :
https://doi.org/10.1111/j.1365-2036.2004.02256.x